Title: Innovation in the Synthesis of Complex Pharmaceuticals
Martin obtained his bachelor’s degree in Chemistry from the University of Surrey, UK (1999), graduating with first class honors. He received his doctoral degree in Organic Chemistry (2002) from the University of Cambridge, UK, working under the direction of Dr. Stuart Warren. His thesis research involved sulfur participation chemistry, specifically the generation of thiiranium ions under basic conditions and their use in pyrrolidine synthesis. Martin then carried out postdoctoral research with Prof. Scott E. Denmark, at the University of Illinois Urbana-Champaign, working on the Lewis-base activation of Lewis-acids and understanding ligand-field theory in hyper-valent silyl cations.
In 2005 Martin joined Bristol Myers Squibb and is currently Executive Director, Head of Portfolio Chemistry in Chemical Process Development (CPD). Martin has led multiple teams through innovation projects, developing novel approaches to complex molecular systems, and designing commercial approaches to important drug candidates, such as the HIV attachment inhibitor Fostemsavir. Martin is currently accountable for CPDs early portfolio programs, commercial route selection and external development activities. Martin is also the co-lead of the BMS-Biocon Research Center (BBRC), a research institute on the campus of Syngene Inc. in Bangalore India, where Martin is accountable for the Product Development facing team.
Additionally, Martin is on the joint research committee (JRC) of the BMS-Scripps collaboration, is a member of the Scientific Advisory Board (SAB) of Asymchem Life Sciences Inc, the Editorial Advisory Board (EAB) for the ACS journal Organic Process Research and Development (OPRD), the Board of Directors for Organic Reactions, is a member of the Scientific Advisory Board (SAB) of Elsie Biosciences and has been a Fellow of the Royal Society of Chemistry (FRSC) since 2018.
Martin has co-authored over 100 peer reviewed publications, is a co-inventor on multiple patent applications and granted patents and has been invited to give more than 100 lectures at conferences and universities world-wide. Martin has been the recipient of several awards including the GlaxoSmithKline Post-Doctoral Fellowship in Organic Chemistry, was selected as a 2011 ACS Young Investigator, was a 2017 McElvain lecturer at the University of Wisconsin, was the inaugural recipient of the ‘Industrial Chemistry Award’ from the International Society of Heterocyclic Chemistry (2017), received the ‘Organic Industrial Chemistry Award’ from the Royal Society of Chemistry (2019), the ‘Ondetti & Cushman Award’ (a scientific honor presented by Bristol Myers Squibb, 2019), is a winner of the EPA Green Chemistry Challenge award (2021), the ‘Industrial Chemistry’ Award by the Philadelphia Organic Chemists Club (POCC, 2021) and was part of a team that received the Robert Robinson ‘Horizon Award’ from the Royal Society of Chemistry (2022).